Immune Cell Infiltration Scores Predict the Prognosis in Patients with Hepatocellular Carcinoma

被引:0
作者
Huang, Lei [1 ]
Jiang, Zong-Wei [1 ]
Fang, Min [1 ]
Li, Chun-Rong [1 ]
Liu, Miao-Feng [1 ]
Liang, Yi-Hua [1 ]
Liu, Jin-Feng [1 ]
Wu, Jun-Rong [1 ]
机构
[1] Guangxi Med Univ, Canc Hosp, Dept Clin Lab, Nanning 530022, Guangxi, Peoples R China
关键词
hepatocellular carcinoma; immunoscore; nomogram; prognosis;
D O I
10.23812/j.biol.regul.homeost.agents.20233712.641
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Immune cell infiltration plays an important role in the occurrence, development, and prognosis of cancer. The pur -pose of this investigation was to explore the relationship between immunoscore and prognosis, and to build a clinical nomogram for predicting survival in hepatocellular carcinoma (HCC) patients. Patients and Methods: A total of 368 subjects were gathered in this study from the Cancer Genome Atlas, and the immunoscore was determined using the ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data) model. To identify prognostic factors, a Cox proportional hazards regression model was used, and multivariate analysis was used to develop the nomogram. The predictive accuracy and discriminating ability of model were verified using concordance indices (C-indices), calibration, Kaplan-Meier analysis and receiver operating characteristic (ROC).Results: We divided the patients into three subgroups based on their immunoscore: low, medium, and high. A higher im-munoscore was associated with significantly better overall survival (OS) and disease-free survival (DFS) than one with a lower immunoscore (hazard ratios (HR) with 95% confidence intervals (CI): 0.50 (0.27-0.92) and 0.39 (0.19-0.82)). Prediction using C-indices for OS was 0.66 (95% CI: 0.61-0.72) and for DFS was 0.74 (95% CI: 0.68-0.80). Nomogram predictions and actual observations showed a significant degree of agreement by ROC and calibration curve for OS and DFS probabilities at 3 and 5 years.Conclusions: HCC patients with high immunoscore have significantly improved OS and DFS. The immunoscore can be consid-ered as a prognostic marker in HCC patients. Moreover, our nomograms may help establish a greater degree of accuracy in predicting prognosis.
引用
收藏
页码:6769 / 6780
页数:12
相关论文
共 37 条
  • [1] MERGE - A SOFTWARE PACKAGE FOR GENERATING A SINGLE DATA-BASE STARTING FROM EMBL AND GENBANK COLLECTIONS
    ATTIMONELLI, M
    LANAVE, C
    LIUNI, S
    PESOLE, G
    [J]. NUCLEIC ACIDS RESEARCH, 1988, 16 (05) : 1681 - 1682
  • [2] Nomograms in oncology: more than meets the eye
    Balachandran, Vinod P.
    Gonen, Mithat
    Smith, J. Joshua
    DeMatteo, Ronald P.
    [J]. LANCET ONCOLOGY, 2015, 16 (04) : E173 - E180
  • [3] X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
    Camp, RL
    Dolled-Filhart, M
    Rimm, DL
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7252 - 7259
  • [4] The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
    Cerami, Ethan
    Gao, Jianjiong
    Dogrusoz, Ugur
    Gross, Benjamin E.
    Sumer, Selcuk Onur
    Aksoy, Buelent Arman
    Jacobsen, Anders
    Byrne, Caitlin J.
    Heuer, Michael L.
    Larsson, Erik
    Antipin, Yevgeniy
    Reva, Boris
    Goldberg, Arthur P.
    Sander, Chris
    Schultz, Nikolaus
    [J]. CANCER DISCOVERY, 2012, 2 (05) : 401 - 404
  • [5] Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma
    Chen, Qi-Feng
    Li, Wang
    Wu, Pei-Hong
    Shen, Lu-Jun
    Huang, Zi-Lin
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (35) : 5266 - 5282
  • [6] Tumour burden and efficacy of immune-checkpoint inhibitors
    Dall'Olio, Filippo G.
    Marabelle, Aurelien
    Caramella, Caroline
    Garcia, Camilo
    Aldea, Mihaela
    Chaput, Nathalie
    Robert, Caroline
    Besse, Benjamin
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (02) : 75 - 90
  • [7] The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma
    Deng, Min
    Sun, Shiquan
    Zhao, Rongce
    Guan, Renguo
    Zhang, Zhen
    Li, Shaohua
    Wei, Wei
    Guo, Rongping
    [J]. MOLECULAR MEDICINE, 2022, 28 (01)
  • [8] Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma
    Dong, Liang-qing
    Peng, Li-hua
    Ma, Li-jie
    Liu, Dong-bing
    Zhang, Shu
    Luo, Shu-zhen
    Rao, Jun-hua
    Zhu, Hong-wen
    Yang, Shuai-xi
    Xi, Shui-jun
    Chen, Min
    Xie, Fan-fan
    Li, Fu-qiang
    Li, Wen-hui
    Ye, Chen
    Lin, Li-ya
    Wang, Yu-jue
    Wang, Xiao-ying
    Gao, Da-ming
    Zhou, Hu
    Yang, Huan-ming
    Wane, Jian
    Zhu, Shi-da
    Wang, Xiang-dong
    Cao, Ya
    Zhou, Jian
    Fan, Jia
    Wu, Kui
    Gao, Qiang
    [J]. JOURNAL OF HEPATOLOGY, 2020, 72 (05) : 896 - 908
  • [9] The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
    Donne, Romain
    Lujambio, Amaia
    [J]. HEPATOLOGY, 2023, 77 (05) : 1773 - 1796
  • [10] The Immune Score as a New Possible Approach for the Classification of Cancer
    Galon, Jerome
    Pages, Franck
    Marincola, Francesco M.
    Thurin, Magdalena
    Trinchieri, Giorgio
    Fox, Bernard A.
    Gajewski, Thomas F.
    Ascierto, Paolo A.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10